Clinical Trials Browser

Phase 1/2 × Unknown × Cetuximab × Clear all

NCT03024489 2024-03-15

Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell Carcinoma

Phase 1/2 Unknown

Head and Neck Neoplasms

NCT02826837 2021-10-06

LEAC-102 for Advanced Colorectal Cancer

Phase 1/2 Unknown

Gastrointestinal

Advanced Colorectal Cancer

NCT04872634 2021-07-21

SNK_ASTER

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02054442 2021-03-12

COMMENCE

Phase 1/2 Unknown

Squamous Cell Carcinoma of Head and Neck

NCT02507154 2018-08-21

NKEXPHNC

Phase 1/2 Unknown

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Neoplasms

NCT03051906 2017-11-22

DUCRO-HN

Phase 1/2 Unknown

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT00425425 2014-05-01

Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer

Phase 1/2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01192087 2013-04-24

ACCEPT

Phase 1/2 Unknown

Carcinoma, Adenoid Cystic

NCT01760811 2013-01-04

CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment in Locally Advanced Tongue Cancer ; A NEW PARADIGM OF TREATMENT

Phase 1/2 Unknown

Carcinoma, Squamous Cell

NCT01166035 2010-07-20

TEXO

Phase 1/2 Unknown

GastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Colorectal Neoplasms

NCT00353717 2009-01-13

Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma

Phase 1/2 Unknown

Breast Neoplasms, Carcinoma, Neoplasm Metastasis

NCT00311857 2006-09-08

Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)

Phase 1/2 Unknown

Glioblastoma